...
首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma.
【24h】

Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma.

机译:英科酮(一种草药)对胆管癌致胆道梗阻患者肝脏的胆汁作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: To investigate the choleretic effects of inchinkoto (ICKT) on livers of patients with biliary obstruction due to bile duct carcinoma. Methods: Twenty-seven patients with bile duct carcinoma who were due to undergo biliary drainage and subsequent major hepatectomy were randomly assigned to preoperative ICKT (n = 13) or untreated (n = 14) groups. ICKT was administered from the day of admission until one day before surgery. Changes in bile constituents, expression of multidrug resistance-associated protein (MRP) 2, MRP3 and MRP4 in the liver, and the incidence of postoperative complications were included as end-points. Results: The biliary concentration of total bilirubin was significantly increased after administration of ICKT (23.7 +/- 2.8 mg/dL before ICKT; 34.0 +/- 4.0 mg/dL after ICKT, P < 0.05). The biliary concentration of total bile acids was also significantly increased. Protein levels of MRP2 and MRP3 in the crude plasma membrane fraction of livers of treated patients were significantly higher than those without treatment. MRP2 staining in the livers of patients without ICKT treatment was weak and diffuse around the bile canaliculi, whereas staining in patients with ICKT treatment was strong and restricted to the bile canaliculi. Conclusion: ICKT exerts a choleretic effect on the livers of patients with biliary obstruction. This beneficial effect was associated with increased expression of MRP2. ICKT thus has therapeutic potential for treatment for obstructive cholestasis due to bile duct carcinoma.
机译:目的:探讨inchinkoto(ICKT)对胆管癌致胆道梗阻患者肝脏的胆汁作用。方法:将因胆汁引流和随后的大肝切除术而导致的胆管癌的27例患者随机分为术前ICKT组(n = 13)或未治疗组(n = 14)。从入院当天至手术前一日给予ICKT。终点包括肝脏中胆汁成分的变化,多药耐药相关蛋白(MRP)2,MRP3和MRP4的表达以及术后并发症的发生率。结果:给予ICKT后,总胆红素的胆汁浓度显着增加(在ICKT前为23.7 +/- 2.8 mg / dL;在ICKT后为34.0 +/- 4.0 mg / dL,P <0.05)。总胆汁酸的胆汁浓度也明显增加。受治疗患者肝脏的粗质膜部分中MRP2和MRP3的蛋白质水平显着高于未经治疗的患者。未接受ICKT治疗的患者肝脏中的MRP2染色较弱且在胆小管周围弥散,而接受ICKT治疗的患者的MRP2染色较强且仅局限于胆小管。结论:ICKT对胆道梗阻患者的肝脏具有胆汁抵抗作用。该有益效果与MRP2表达增加有关。因此,ICKT对于胆管癌引起的阻塞性胆汁淤积具有治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号